BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10449950)

  • 1. Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course.
    Quaglino P; Zaccagna A; Verrone A; Dardano F; Bernengo MG
    Dermatology; 1999; 199(1):8-14. PubMed ID: 10449950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilesional mycosis fungoides: a study of seven cases.
    Hodak E; Phenig E; Amichai B; Feinmesser M; Kuten A; Maron L; Sahar D; Bergman R; David M
    Dermatology; 2000; 201(4):300-6. PubMed ID: 11146338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mycosis fungoides in children and adolescents: a report of six cases with predominantly hypopigmentation, along with a literature review].
    Rizzo FA; Vilar EG; PantaleĆ£o L; Fonseca EC; Magrin PF; Henrique-Xavier M; Rochael MC
    Dermatol Online J; 2012 Mar; 18(3):5. PubMed ID: 22483516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
    Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
    Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
    Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
    Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
    Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
    Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.
    Abbott RA; Sahni D; Robson A; Agar N; Whittaker S; Scarisbrick JJ
    J Am Acad Dermatol; 2011 Aug; 65(2):313-319. PubMed ID: 21529998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
    Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
    J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
    Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG;
    Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
    Moore PF; Olivry T; Naydan D
    Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD20+ mycosis fungoides: a report of three cases and review of the literature.
    Hagen JW; Schaefer JT; Magro CM
    Am J Dermatopathol; 2013 Dec; 35(8):833-41. PubMed ID: 24247573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypopigmented mycosis fungoides versus mycosis fungoides with concomitant hypopigmented lesions: same disease or different variants of mycosis fungoides?
    Furlan FC; Pereira BA; Sotto MN; Sanches JA
    Dermatology; 2014; 229(3):271-4. PubMed ID: 25323446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Martinez-Escala ME; Kantor RW; Cices A; Zhou XA; Kaplan JB; Pro B; Choi J; Guitart J
    J Am Acad Dermatol; 2017 Sep; 77(3):489-496. PubMed ID: 28676328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides.
    Khopkar U; Doshi BR; Dongre AM; Gujral S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):167-73. PubMed ID: 21393946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
    Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
    J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low CD7 expression in benign and malignant cutaneous lymphocytic infiltrates: experience with an antibody reactive with paraffin-embedded tissue.
    Murphy M; Fullen D; Carlson JA
    Am J Dermatopathol; 2002 Feb; 24(1):6-16. PubMed ID: 11803274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+, CD56+ mycosis fungoides: case report and review of the literature.
    Horst BA; Kasper R; LeBoit PE
    Am J Dermatopathol; 2009 Feb; 31(1):74-6. PubMed ID: 19155730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype.
    El-Shabrawi-Caelen L; Cerroni L; Medeiros LJ; McCalmont TH
    Am J Surg Pathol; 2002 Apr; 26(4):450-7. PubMed ID: 11914622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.